Symbol: GRFS Sector: Healthcare Industry: Drug Manufacturers
| Dividend Yield: | 1.19% | |
| Dividend per Share: | $ 0.2629 | |
| Next Ex-Div Date: | 2019-06-07 | |
| Next Div Payout: | $ 0.1314 | |
| Payment Schedule: | Half Yearly | - |
| Payout Ratio (ttm) | n.a. |
| Ø 3yr Growth Rate | +1.36 % | +0.55% |
| Ø 5yr Growth Rate | +0.82 % | - |
| Type: | Common Stock |
| Exchange: | Nasdaq Global Select |
| Current Price (*): | $ 22.10 |
| Week 52 high: | $ 24.97 |
| Week 52 low: | $ 17.42 |
| Marketcap | $ 13,258,542,986 |
| Return on Equity | 14.00 % |
| P/E Ratio high | 33.30 |
| P/E Ratio low | 15.00 |
About: Grifols SA is a pharmaceutical company. It primarily collects the liquid portion of human blood called plasma and then manufactures and sells plasma-derived products globally. It also operates diagnostics, hospital supplies, and raw materials businesses.
Tags: Biotechnology Drug Manufacturers Drug Manufacturers - Major Healthcare
Website: http://www.grifols.com